HUP0201975A3 - Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs - Google Patents
Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugsInfo
- Publication number
- HUP0201975A3 HUP0201975A3 HU0201975A HUP0201975A HUP0201975A3 HU P0201975 A3 HUP0201975 A3 HU P0201975A3 HU 0201975 A HU0201975 A HU 0201975A HU P0201975 A HUP0201975 A HU P0201975A HU P0201975 A3 HUP0201975 A3 HU P0201975A3
- Authority
- HU
- Hungary
- Prior art keywords
- drugs
- contrast agents
- diagnostic imaging
- bioactive substances
- imaging contrast
- Prior art date
Links
- 230000000975 bioactive effect Effects 0.000 title 1
- 239000000969 carrier Substances 0.000 title 1
- 239000002872 contrast media Substances 0.000 title 1
- 239000000412 dendrimer Substances 0.000 title 1
- 229920000736 dendritic polymer Polymers 0.000 title 1
- 238000002059 diagnostic imaging Methods 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/641—Branched, dendritic or hypercomb peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1999FO000015A ITFO990015A1 (it) | 1999-07-23 | 1999-07-23 | "dendrimeri polipeptidici quali trasportatori unimolecolari di farmaci e sostanze biologicamente attive". |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0201975A2 HUP0201975A2 (en) | 2002-10-28 |
| HUP0201975A3 true HUP0201975A3 (en) | 2002-11-28 |
Family
ID=11353680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0201975A HUP0201975A3 (en) | 1999-07-23 | 2000-07-21 | Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1200461A2 (ja) |
| JP (1) | JP2003506326A (ja) |
| CN (1) | CN1364171A (ja) |
| AU (1) | AU772167B2 (ja) |
| CA (1) | CA2380178A1 (ja) |
| HU (1) | HUP0201975A3 (ja) |
| IT (1) | ITFO990015A1 (ja) |
| NO (1) | NO20020333L (ja) |
| NZ (1) | NZ517231A (ja) |
| PL (1) | PL353273A1 (ja) |
| WO (1) | WO2001007469A2 (ja) |
| ZA (1) | ZA200201089B (ja) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR032941A1 (es) | 2001-03-05 | 2003-12-03 | Shell Int Research | Un procedimiento para preparar un aceite base lubricante y aceite base obtenido, con sus diversas utilizaciones |
| MY139353A (en) | 2001-03-05 | 2009-09-30 | Shell Int Research | Process to prepare a lubricating base oil and a gas oil |
| MY137259A (en) | 2001-03-05 | 2009-01-30 | Shell Int Research | Process to prepare a lubricating base oil and a gas oil. |
| WO2003037383A1 (en) * | 2001-10-29 | 2003-05-08 | The Dow Chemical Company | An antineoplastic- dendritic polymer drug delivery system |
| AU2003255058A1 (en) | 2002-07-18 | 2004-02-09 | Shell Internationale Research Maatschappij B.V. | Process to prepare a microcrystalline wax and a middle distillate fuel |
| EP1525890A1 (en) * | 2003-10-02 | 2005-04-27 | Complex Biosystems GmbH | Protein-Proteophore complexes |
| JP5401095B2 (ja) | 2005-11-17 | 2014-01-29 | ゾゲニクス インコーポレーティッド | 無針注射による粘性製剤の送達方法 |
| HUP0700782A3 (en) * | 2007-12-05 | 2009-11-30 | Biostatin Gyogyszerkutato Fejl | Novel peptides and amino acid derivatives, pharmaceutical compositions containing the same and use of the compounds |
| EP2756756B1 (en) | 2008-04-28 | 2016-01-06 | Zogenix, Inc. | Novel formulations for treatment of migraine |
| NZ591052A (en) * | 2008-08-05 | 2012-11-30 | Univ Queensland | Antigen-presenting scaffolds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995000540A1 (en) * | 1993-06-18 | 1995-01-05 | Robert Webber | Synthetic carrier and immunogen |
| EP1011736A2 (en) * | 1997-01-29 | 2000-06-28 | Nycomed Imaging As | Polymers |
-
1999
- 1999-07-23 IT IT1999FO000015A patent/ITFO990015A1/it unknown
-
2000
- 2000-07-21 CA CA002380178A patent/CA2380178A1/en not_active Abandoned
- 2000-07-21 WO PCT/EP2000/007022 patent/WO2001007469A2/en not_active Application Discontinuation
- 2000-07-21 CN CN00810769A patent/CN1364171A/zh active Pending
- 2000-07-21 PL PL00353273A patent/PL353273A1/xx not_active Application Discontinuation
- 2000-07-21 HU HU0201975A patent/HUP0201975A3/hu unknown
- 2000-07-21 AU AU62766/00A patent/AU772167B2/en not_active Ceased
- 2000-07-21 EP EP00949393A patent/EP1200461A2/en not_active Withdrawn
- 2000-07-21 NZ NZ517231A patent/NZ517231A/en unknown
- 2000-07-21 JP JP2001512552A patent/JP2003506326A/ja active Pending
-
2002
- 2002-01-22 NO NO20020333A patent/NO20020333L/no not_active Application Discontinuation
- 2002-02-07 ZA ZA200201089A patent/ZA200201089B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6276600A (en) | 2001-02-13 |
| NO20020333D0 (no) | 2002-01-22 |
| ZA200201089B (en) | 2003-07-30 |
| JP2003506326A (ja) | 2003-02-18 |
| WO2001007469A3 (en) | 2001-05-10 |
| CN1364171A (zh) | 2002-08-14 |
| HUP0201975A2 (en) | 2002-10-28 |
| PL353273A1 (en) | 2003-11-03 |
| AU772167B2 (en) | 2004-04-08 |
| NZ517231A (en) | 2003-05-30 |
| EP1200461A2 (en) | 2002-05-02 |
| CA2380178A1 (en) | 2001-02-01 |
| ITFO990015A1 (it) | 2001-01-23 |
| WO2001007469A2 (en) | 2001-02-01 |
| NO20020333L (no) | 2002-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0203325A3 (en) | Bicyclic amino acids, pharmaceutical compositions containing them and their use | |
| CZ20012028A3 (cs) | Nové N-substituované 2-kyanopyrrolidiny, farmaceutický prostředek, který je obsahuje a jejich použití jako léčivo | |
| HUP0004400A3 (en) | Dipeptide nitriles, process for their preparation, pharmaceutical compositions comprising thereof and their use | |
| ZA200202996B (en) | Hair treatment compositions comprising particulate substances. | |
| HUP0204413A3 (en) | Quinazoline compounds, their preparation, their use and pharmaceutical compositions containing them | |
| HUP0100270A3 (en) | Peptids for inhibiting betha-amyloid peptide release and/or its synthesis, pharmaceutical compositions comprising thereof and their use | |
| HUP0200831A3 (en) | Novel pharmaceutical composition containing amoxycillin and its use | |
| EE200200046A (et) | 8-fenüül-6,9-dihüdro-[1,2,4]triasolo[3,4-i]puriin-5-ooni derivaat, selle valmistamine ja raviotstarbeline kasutamine ning seda sisaldav farmatseutiline kompositsioon | |
| HUP0103265A3 (en) | Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use | |
| HUP0204081A3 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| HUP0203194A3 (en) | Phenylpiperazines, pharmaceutical compositions containing them and their use | |
| ZA971869B (en) | Implants with phasewise release of pharmaceutical substance. | |
| HUP0201975A3 (en) | Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs | |
| NZ513650A (en) | Pharmaceutical composition for the treatment of urinary incontinence, motion sickness and vertigo | |
| ZA991974B (en) | Bicyclic aromatic compounds and their use in human or veterinary medicine, as well as in cosmetology. | |
| IL156262A0 (en) | Anti-cd28 antibodies having no mitogenic activity and pharmaceutical compositions containing the same | |
| EP1210416A4 (en) | GENES CODING PROTEINS FOR DIAGNOSTIC, PREVENTIVE AND THERAPEUTIC USE | |
| HUP0201910A3 (en) | Novel aminobenzophenones, pharmaceutical compositions containing them and their use | |
| HK1029928A1 (en) | Pharmaceutical compositions of peptides having lowsolubility in physiological medium. | |
| HUP0201696A3 (en) | Cyclic peptides, pharmaceutical compositions comprising thereof and their use | |
| ZA200109989B (en) | Pharmaceutical composition containing sibutramine and orlistat. | |
| DE69831223D1 (de) | Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52 | |
| IL121329A (en) | Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides | |
| HU9802590D0 (en) | Sulfonamid-substituted and condensed compounds containing 5-membred ring, their use as medicament and pharmaceutical compositions containing them | |
| IL131266A0 (en) | Peptides and pharmaceutical compositions comprising same |